We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sophia Zoungas

Sophia Zoungas MD, PhD

Senior Staff Specialist in Endocrinology and Diabetes, Alfred Health and Monash Health; Professor of Diabetes, Vascular Health and Ageing; Head of the School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia

Professor Sophia Zoungas is an endocrinologist with a national and international reputation as a clinician researcher in the fields of diabetes and cardiovascular health. She is Head, School of Public Health and Preventive Medicine, Monash University and Professor of Diabetes, Vascular Health and Ageing.

Her major research focus is the design and conduct of large, multicentre, randomised clinical trials and implementation projects that answer important clinical questions. Professor Zoungas has led one of the largest and longest clinical trial of intensive glucose and blood pressure management in diabetes and is currently leading the largest, international community-based clinical trial of statins in older adults ≥70 years. Her research has resulted in changes to treatment recommendations by many national and international bodies including the US Food and Drug Administration, American Diabetes Association, Kidney Disease: Improving Global Outcomes and NHF/NHMRC. Papers on which she is author have been cited over 15,500 times.

Disclosures

Dr. Zoungas reports the following: 
Amgen Australia Pty Ltd, AstraZeneca Pty Ltd, Boehringer Ingelheim, Eli Lilly Australia, Merck Sharp & Dohme (Australia) Pty Ltd, Novo Nordisk, Sanofi: Participation in Advisory Board, expert committees or educational meeting on behalf of Monash University - payment to institution.

Recent Contributions to PracticeUpdate:

  1. T2D Onset Age and CVD Mortality